Similar articles

• [Significance, of the determination of cytotoxic antibodies for thyroid cells in thyroid pathology].

  Winand R, Winand-Devigne J. Winand R, et al. Rev Med Liege. 1976 Aug 1;31(15):460-2. Rev Med Liege. 1976. PMID: 981847 French. No abstract available.
• Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody responses and outcome of therapy.

  Gamstedt A, Karlsson A. Gamstedt A, et al. J Clin Endocrinol Metab. 1991 Jul;73(1):125-31. doi: 10.1210/jcem-73-1-125. J Clin Endocrinol Metab. 1991. PMID: 2045463 Clinical Trial.
• Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis.

  Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A. Chiovato L, et al. J Clin Endocrinol Metab. 1993 Dec;77(6):1700-5. doi: 10.1210/jcem.77.6.7903315. J Clin Endocrinol Metab. 1993. PMID: 7903315
• Thyroid autoantibody levels during lithium therapy.

  Deniker P, Eyquem A, Bernheim R, Loo H, Delarue P. Deniker P, et al. Neuropsychobiology. 1978;4(5):270-5. doi: 10.1159/000117640. Neuropsychobiology. 1978. PMID: 673164
• [Apoptosis and the thyroid: the Fas pathway].

  Vlaeminck-Guillem V, d'Herbomez-Boidein M, Decoulx M, Wémeau JL. Vlaeminck-Guillem V, et al. Presse Med. 2001 Jan 20;30(2):74-80. Presse Med. 2001. PMID: 11244819 Review. French.